Anthem Biosciences share price made a stellar debut in the Indian stock market today, July 21, after its initial public offering (IPO) received a strong demand.

Anthem Biosciences share price Highlights: Anthem Biosciences had a robust launch on the stock exchanges today. On the NSE, the stock began trading at ₹723.05 each, reflecting a 26.85% rise over ...

Satellos Bioscience (TSX: MSCL:CA) appointed Wildon Farwell, M.D., MPH, as chief medical officer. Dr. Farwell joins Satellos from Dyne Therapeutics (DYN), where he most recently served as CMO and ...

SOUTH SAN FRANCISCO, Calif., July 14, 2025--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector ...

LOS ANGELES, July 14, 2025--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of ...

Anthem Bioscience to make its market debut today, July 21. Investor eyes are now on whether the stock will deliver a big bang debut or face market jitters. Here’s what the GMP and key IPO ...

Anthem Biosciences IPO Allotment status, Anthem IPO GMP Price: Anthem Biosciences IPO allotment status set to go live today after oversubscription; check your allotment now!

Investing.com - H.C. Wainwright lowered its price target on Lexaria Bioscience (NASDAQ: LEXX) to $4.00 from $5.00 on Tuesday, while maintaining a Buy rating on the stock. Currently trading at $0. ...

H.C. Wainwright analysts maintained a Buy rating for Daré Bioscience, following a new partnership with Rosy Wellness to promote the company’s sildenafil cream.

Anthem Biosciences IPO oversubscribed, set to list with 20-25% gain, raising ₹1,016 crore from anchor investors.

Anthem Biosciences IPO Allotment (July 17): How to check status on BSE, NSE, and registrar KFin Tech Anthem Biosciences IPO: Once shares are allotted, successful bidders will receive shares in their ...

Anthem Biosciences IPO oversubscribed 63.86 times, attracting strong QIB support, raising ₹1,016 crore from anchor investors.